Gastrointestinal Cancers Detection Arverne NY

DNA testing of a person's stool in Arverne can accurately screen for more types of cancer than previously thought, a new study has found. While DNA stool testing has been successfully used for early detection of colorectal cancer, researchers at Minnesota's Mayo Clinic have found that the noninvasive screening is also good at finding other gastrointestinal cancers, such as those of the pancreas, stomach, bile ducts and esophagus.

Local Companies

Obrien Stephen
(212) 606-1011
535 E 70th St
New York, NY
Esther Friedenthal
(718) 920-4361
Albert Einstein Coll Med
Bronx, NY
Mordechai Beityakov
(718) 376-7894
1731 E 17Th St
Brooklyn, NY
Patrick Hennessey
(718) 797-3333
142 Joralemon St
Brooklyn, NY
Joshua Lowy
(718) 331-9600
6433 99th St Apt 5D
Rego Park, NY
Charles Ellis Connant
(201) 459-8888
324 Palisade Avenue
Jersey City, NJ
Gina Wang
(212) 682-3753
345 E 37Th St # 310
New York, NY
Louis Alosco MD
(718) 792-5566
1120 Morris Park Ave
Bronx, NY
Farangis Manshadi Tavakoli
(718) 745-0555
56 Battery Ave
Brooklyn, NY
Jeong Lee
(718) 852-0716
14-16 Heyward St
Brooklyn, NY
Data Provided by:
  

Provided By:

TUESDAY, June 2 (HealthDay News) -- DNA testing of a person's stool can accurately screen for more types of cancer than previously thought, a new study has found.

While DNA stool testing has been successfully used for early detection of colorectal cancer, researchers at Minnesota's Mayo Clinic have found that the noninvasive screening is also good at finding other gastrointestinal cancers, such as those of the pancreas, stomach, bile ducts and esophagus.

"Historically, we've approached cancer screening one organ at a time," the study's lead researcher, Dr. David Ahlquist, a Mayo Clinic gastroenterologist, said in a news release. "Stool DNA testing could shift the strategy of cancer screening to multi-organ, whole-patient testing and could also open the door to early detection of cancers above the colon, which are currently not screened." The potential could be enormous, he said.

The findings, to be presented in Chicago at the Digestive Disease Week 2009 conference, is based on a study of patients with cancers throughout the digestive tract and healthy control subjects. The test developed by Mayo Clinic researchers, which checked a patient's stool for the DNA of cells regularly shed from the surface of several types of tumors, detected 65 percent of esophageal cancers, 62 percent of pancreatic cancers, 75 percent of bile duct and gallbladder cancers and 100 percent of stomach and colorectal cancers. The test was equally successful at detecting early-stage and late-stage cancers.

One in four cancer deaths are the result of gastrointestinal cancers, the news release notes. These cancers are quite curable if detected at an early stage, but the only one widely tested for is colorectal cancer, generally through colonoscopy.

"Patients are often worried about invasive tests like colonoscopies, and yet these tests have been the key to early cancer detection and prevention," Ahlquist said. "Our research team continues to look for more patient-friendly tests with expanded value, and this new study reveals an opportunity for multi-organ, digestive cancer screening with a single noninvasive test."

He said the next step will be refining the tests to further improve accuracy, tumor-site prediction, speed, ease of use and affordability.

More information

The American Cancer Society has more about stomach cancer.

SOURCE: Mayo Clinic, news release, June 2, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Diagnosis of Prostate Cancer Arverne NY
Mass screening for prostate cancer with a test for prostate-specific antigen (PSA) has led to mass over-diagnosis and over-treatment, a new study contends. Since the PSA screening test came into use in 1986, federal government data show that the number of prostate cancer cases in the United States has risen substantially, said the report in the Aug. 31 online issue of the Journal of the National Cancer Institute.
- Early Colon Cancer Detection Arverne NY
- Risks for Childhood Cancer Survivors Arverne NY
- Breast Cancer Treatment Arverne NY
- CT Imaging Arverne NY
- Follow Up After Skin Cancer Arverne NY
- EBT Scans Arverne NY
- Risk Factors for Squamous Cell Cancer of the Skin Arverne NY
- Early Breast Cancer Detection Arverne NY